<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250207064675N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-02-19</date_registration>
      <primary_sponsor>Riphah International University Islamabad</primary_sponsor>
      <public_title>Effects of Gong’s Mobilization Vs Mulligan Mobilization on Pain, Proprioception and Sleep Quality In Adhesive Capsulitis Patients</public_title>
      <acronym></acronym>
      <scientific_title>Effects of Gong’s Mobilization Vs Mulligan Mobilization on Pain, Proprioception and Sleep Quality In Adhesive Capsulitis Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-10-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/81863</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization Methodology
In this study, simple randomization was used to allocate participants into two intervention groups: Gong Mobilization and Mulligan Mobilization. Simple randomization ensures that each participant has an equal chance of being assigned to either group, reducing selection bias.
Unit of Randomization
The individual was used as the unit of randomization. Each participant was independently randomized into one of the two intervention groups, ensuring that treatment allocation was not influenced by external factors such as therapist preference or participant characteristics.
Randomization Strata in Stratified Randomization
Stratification was not used in this study. However, in future studies, stratified randomization could be applied to ensure balance among important variables such as age, gender, and severity of adhesive capsulitis.
Tools Used for Randomization
The randomization process was conducted using the sealed envelope method, a widely accepted technique for ensuring allocation concealment. A total of 30 sealed envelopes were prepared, with 15 assigned to the Gong Mobilization group and 15 to the Mulligan Mobilization group. Each envelope contained a card labeled with one of the two interventions. The envelopes were identical in appearance, shuffled, and drawn by participants to determine their group assignment.
Construction of the Random Sequence
A computer-generated random sequence was used to determine the group assignments before placing them into the sealed envelopes. The sequence was generated using Microsoft Excel’s RAND function to ensure an unbiased allocation process. The sequence was then printed and enclosed in the sealed envelopes to maintain allocation concealment.
Allocation Concealment
Allocation concealment was ensured in this study to prevent selection bias. The sealed envelope method was used, ensuring that neither the participants nor the principal investigator knew the group assignments in advance. The envelopes were only opened after the participant provided informed consent, ensuring an unbiased allocation process.
By implementing this method of randomization, the study minimized selection bias and maintained the integrity of the intervention comparisons, Blinding description: Blinding Methodology
Blinding was implemented in this study to minimize bias and improve the reliability of results. While a full double- or triple-blind design was not feasible due to the nature of physiotherapy interventions, the following groups were blinded to various extents:
1. Participants
Participants in this study were not blinded to their intervention group, as they were actively engaged in the Gong Mobilization or Mulligan Mobilization treatment sessions. Given the hands-on nature of the interventions, it was not possible to conceal the treatment they received. However, participants were not informed of the specific hypothesis regarding which intervention was expected to be more effective.
2. Principal Investigator
The principal investigator, who also supervised the study, was not blinded, as they were involved in the randomization process and oversight of treatment administration. However, to minimize bias, the principal investigator did not participate in data collection or outcome assessment.
3. Healthcare Providers (Physiotherapists Administering the Intervention)
The physiotherapists who administered the interventions were not blinded, as they needed to apply the respective mobilization techniques according to protocol. However, they were instructed to follow standardized treatment procedures and not discuss expected outcomes with participants.
4. Data Collectors
Blinding was ensured for data collectors. They were not aware of the participants' group allocation when recording data. The assessments of pain (VAS), sleep quality (PSQI), and proprioception (LP-ART) were conducted using standardized measurement tools, reducing subjective bias in data collection.
5. Outcome Assessors
The outcome assessors were blinded to group allocation. To achieve this, participants were instructed not to disclose their treatment details during assessments. Additionally, data were recorded in a way that did not indicate the intervention group, ensuring that assessors remained unbiased when analyzing the results.
6. Data Safety and Monitoring Board (DSMB)
This study did not involve a formal Data Safety and Monitoring Board (DSMB), as it was a short-term, non-pharmacological intervention with a low risk of adverse effects. However, ethical oversight was maintained by the Institutional Review Board (IRB).
7. Manuscript Writers
The individuals involved in manuscript writing were partially blinded during the initial data analysis. The dataset used for statistical analysis was coded to obscure the intervention groups, ensuring that data interpretation remained objective until final results were compiled.</study_design>
      <phase>1</phase>
      <hc_freetext>Adhesive Capsulitis is a disorder affecting the muscles and soft tissues of the shoulder progressively limiting the range of motion in both passive and active, stiffness, and pain which is present in night and daytime in glenohumeral joint..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Gong’s Mobilization. Intervention 2: Intervention group: Mulligan Mobilization.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is More work will be done on the data for further studies and analysis will be performed which is very confidential.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Muhammad Zeshan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Gulberg Greens Block D expressway</address>
        <city>Islamabad</city>
        <country1>Pakistan</country1>
        <zip>32034</zip>
        <telephone>+92 333 6456828</telephone>
        <email>ptzeshankhan@gmail.com</email>
        <affiliation>Riphah International University Islamabad</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Muhammad Zeshan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>House 453 street 41 tauheed property dealer Zakariya town Multan</address>
        <city>Multan</city>
        <country1>Pakistan</country1>
        <zip>60000</zip>
        <telephone>+92 333 6456828</telephone>
        <email>ptzeshankhan@gmail.com</email>
        <affiliation>Riphah International University Islamabad</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with unilateral Adhesive Capsulitis
History of Shoulder joint pain and shoulder stiffness for more than 3 months
Person with bad sleep quality, and diagnosed with ≥5 score in PSQI
Person with Abduction ≥ 50º</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Participants with history of shoulder surgery
Post traumatic shoulder pain &amp; stiffness
Recent History of fracture
Diagnosed instability and history of dislocation
Congenital abnormalities of Shoulder
Systemic inflammatory conditions (RA)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M75.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Adhesive capsulitis of shoulder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Gong’s Mobilization</i_keyword>
      <i_keyword>Intervention group: Mulligan Mobilization</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Visual Analog Scale Pain. Timepoint: Each group was assessed at baseline and after 2 weeks (6 sessions per week) of intervention which included pain through VAS. Method of measurement: VAS is described as a 10-cm line. No pain at left end of line and the worst conceivable pain at right end of the line. Patient is asked to mark at 10 cm line to inform pain magnitude. Visual Analog Scale is an extremely reliable and synchronously valid pain measurement tool.</prim_outcome>
      <prim_outcome>Laser-Pointer Assisted Angle Reproduction Test (LP-ART) Proprioception. Timepoint: Each group was assessed at baseline and after 2 weeks (6 sessions per week) of intervention which included proprioception through laser pointer angle reproduction test. Method of measurement: The person being tested was standing at a dotted line on the floor that was drawn parallel and one hundred CM distance to a target board fixed on the opposite wall. The target board was adjusted in height to the subject so that point zero could be aligned individually with the glenohumeral joint of every subject. A standardized coordinate system drawn on the target board with successive 4cmmarkings up to a distance of 22 cm. A laser pointer was be fixed at the back side of the patient’s wrist with a strap. The test subject was asked to raise their affected arm from hanging (neutral) position to aim for assigned points at 55°,90° and 125°. The90°position was defined as zero point. The patient was required to memorize the different joint positions at different degrees. In the next step, the patient’s eyes was blind folded to inhibit visual control. Then they were asked to reproduce the same joint positions as before in a randomized order. The coordinated distance of the position where the laser pointer finally comes to rest was marked, documented by an independent checker, without telling the subject. This procedure was repeated 3 times for flexion and abduction respectively. The deviations of the given angles (55°,90°, 125°) was measured on the x- and y-axis in CM.</prim_outcome>
      <prim_outcome>Pittsburgh sleep index. Timepoint: Each group was assessed at baseline and after 2 weeks (6 sessions per week) of intervention which included sleep quality through Pittsburg Sleep Index. Method of measurement: Sleep quality was assessed by PSQI tool, an instrument with known validity and reliability . The PSQI tool consists of 19 self-reporting questions, each having an ordinal grading scale ranging from 0 to 3, where 0 represents no current issues and 3reflects the most negative quality of sleep. These 19 questions are further divided into7 subjective sub-categories that include sleep quality, sleep duration, sleep latency, sleep disturbance, habitual sleep efficiency, use of sleep-inducing medications, and daytime dysfunction. The 7 subcategories are then summed up to yield a global PSQI score, which has a range of 0 to 21, with higher scores indicative of poorer sleep quality. This sleep index tool (PSQI) has satisfactory internal consistency with a Cronbach reliability coefficient of 0.83 and has been validated in multiple languages. A global sum of 5 or greater indicates a poor sleeper based on a sensitivity of 0.90, specificity of 0.87 with a k value of 0.75 in distinguishing sleep quality.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Riphah International University Islamabad</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-02</approval_date>
        <contact_name>Riphah College of Rehabilitation Sciences, Riphah International University Islamabad EMAIL: waqar.ah</contact_name>
        <contact_address>Gulberg Green Campus D Block Gulberg Express way Islamabad Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
